1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Insulin Pens Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Insulin Pens Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Insulin Pens Market Regional Analysis
6.2 Europe Insulin Pens Market Revenue 2016-2027 (US$ Million)
6.3 Europe Insulin Pens Market Forecast Analysis
7. Europe Insulin Pens Market Analysis – by Product Type
7.1 Disposable
- 7.1.1 Overview
- 7.1.2 Disposable: Europe Insulin Pens Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Reusable
- 7.2.1 Overview
- 7.2.2 Reusable: Europe Insulin Pens Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. Europe Insulin Pens Market Analysis – by Application
8.1 Diabetes Type-1
- 8.1.1 Overview
- 8.1.2 Diabetes Type-1: Europe Insulin Pens Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Diabetes Type-2
- 8.2.1 Overview
- 8.2.2 Diabetes Type-2: Europe Insulin Pens Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. Europe Insulin Pens Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Europe Insulin Pens Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Retail Pharmacies and e-Commerce
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies and e-Commerce: Europe Insulin Pens Market – Revenue and Forecast, 2016-2027 (US$ Million)
10. Europe Insulin Pens Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Insulin Pens Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.2.1.1 Europe Insulin Pens Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 UK: Europe Insulin Pens Market Breakdown, by Product Type
- 10.2.1.1.2 UK: Europe Insulin Pens Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Insulin Pens Market Breakdown, by Distribution Channel
- 10.2.1.2 Germany:
Europe Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Germany: Europe Insulin Pens Market Breakdown, by Product Type
- 10.2.1.2.2 Germany: Europe Insulin Pens Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Insulin Pens Market Breakdown, by Distribution Channel
- 10.2.1.3 France:
Europe Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 France: Europe Insulin Pens Market Breakdown, by Product Type
- 10.2.1.3.2 France: Europe Insulin Pens Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Insulin Pens Market Breakdown, by Distribution Channel
- 10.2.1.4 Russia:
Europe Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Russia: Europe Insulin Pens Market Breakdown, by Product Type
- 10.2.1.4.2 Russia: Europe Insulin Pens Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Insulin Pens Market Breakdown, by Distribution Channel
- 10.2.1.5 Italy:
Europe Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Italy: Europe Insulin Pens Market Breakdown, by Product Type
- 10.2.1.5.2 Italy: Europe Insulin Pens Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Insulin Pens Market Breakdown, by Distribution Channel
- 10.2.1.6 Rest of Europe:
Europe Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Insulin Pens Market Breakdown, by Product Type
- 10.2.1.6.2 Rest of Europe: Europe Insulin Pens Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Insulin Pens Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Owen Mumford, LTD.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Novo Nordisk a/s
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Companion Medical
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Berlin-Chemie AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pendiq GmbH
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Emperra GmbH E-Health Technologies
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Eli lilly and company
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Ypsomed Ag
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 SANOFI
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Biocon
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Insulin Pens Market
